Ollin Biosciences Stock
Ollin Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative therapies for vision-threatening ophthalmic diseases. The company is advancing a pipeline of bispecific antibody candidates designed to target multiple disease pathways simultaneously, aiming to improve treatment efficacy and patient outcomes. With a commitment to addressing unmet medical needs, Ollin Biosciences is dedicated to redefining the standard of care in ophthalmology.
Sign up for SecondMarket® to view the market and buy or sell Ollin Biosciences Stock
Buy + SellOllin Biosciences Funding
Sign up to gain insights into Ollin Biosciences funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series A | Sep 17, 2025 | 100.00M | ||
| Series A | Jul 12, 2024 | 14.35M |
See Ollin Biosciences Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Ollin Biosciences Stock Valuation + Share Prices
View real-time Tape D® data on Ollin Biosciences stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Ollin Biosciences Management Team
-
Board Member
Fred Cohen
-
Board Member
Travis Murdoch
-
Board Member
Paul Berns
-
CEO, Co-Founder
Jason Ehrlich
-
Board Member
Alaa Halawa
-
Board Member
Jason Coloma
-
Board Member
Jason Ehrlich
Ollin Biosciences Major Investors
-
ARCH Venture Partners
-
Monograph Capital
-
Mubadala Capital
Learn More About Ollin Biosciences Stock
Buy Ollin Biosciences Stock
01Ollin Biosciences stock does not trade on public stock exchanges. Ollin Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ollin Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Ollin Biosciences Stock
02Ollin Biosciences Stock does not trade on public stock exchanges. In order to sell Ollin Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Ollin Biosciences Stock Price
03Ollin Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Ollin Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
Ollin Biosciences Stock Ticker Symbol
04There is no ticker symbol for Ollin Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Ollin Biosciences Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ollin Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Ollin Biosciences Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ollin Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Ollin Biosciences Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Ollin Biosciences IPO
08Ollin Biosciences is a private company and has not had an IPO. There is currently no Ollin Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Ollin Biosciences IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Ollin Biosciences Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
